SEC Filings | Madrigal Pharmaceuticals.

Filing date	Form	Description	View
January 08, 2024	8-K	Report of unscheduled material events or corporate event	0001193125-24-004269.pdf 0001193125-24-004269.rtf 0001193125-24-004269.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
January 03, 2024	UPLOAD	UPLOAD	0000000000-24-000087.pdf 0000000000-24-000087.rtf
December 18, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-071116.pdf 0000950170-23-071116.rtf 0000950170-23-071116.xls
December 14, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-070416.pdf 0000950170-23-070416.rtf 0000950170-23-070416.xls
December 14, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-058691.pdf 0001209191-23-058691.rtf 0001209191-23-058691.xls
December 14, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-058693.pdf 0001209191-23-058693.rtf 0001209191-23-058693.xls
December 14, 2023	CORRESP	CORRESP	0001193125-23-295310.pdf 0001193125-23-295310.rtf 0001193125-23-295310.xls
December 13, 2023	SC 13D/A	An amendment to a SC 13D filing	0001193125-23-294326.pdf 0001193125-23-294326.rtf 0001193125-23-294326.xls
December 11, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-020582.pdf 0000899243-23-020582.rtf 0000899243-23-020582.xls
December 08, 2023	CORRESP	CORRESP	0001193125-23-291715.pdf 0001193125-23-291715.rtf

Data provided by Kaleidoscope.